The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center and GlaxoSmithKline (GSK) are pleased to announce a post-doctoral fellowship position that will focus on the economics of vaccination and infectious diseases. The expected start date of the fellowship is September 2019.
This two-year fellowship program, sponsored by GSK, will provide an excellent opportunity to gain unique and in-depth applied work experience in health and economic outcomes studies relating to vaccines. The program will train a qualified candidate in health economic evaluation, outcomes research, decision sciences, and health policy analysis. The overall goal of the fellowship program is to help prepare the fellow for careers in pharmaceutical industry, academic, or consulting settings.
In the first year, the fellow will train at the Center for the Evaluation of Value and Risk in Health (CEVR), located at Tufts Medical Center in Boston, MA. The fellow will collaborate with CEVR faculty to conduct health economics and outcomes research with a focus on vaccines. The fellow will investigate key analytic issues and produce original manuscripts using data from the open-access, Tufts CEVR Global Health Cost-Effectiveness Analysis (GH CEA) Registry (www.ghcearegistry.org), among other data sources. The GH CEA Registry is a cost-per-DALY averted database maintained by CEVR and funded by the Bill and Melinda Gates Foundation. The fellow may also aid with additional vaccine-related analyses stemming from CEVR’s ongoing global health deliverables and international research partnerships.
At CEVR, the fellowship provides training under the direction of Peter J. Neumann, Sc.D. (CEVR’s Director), Joshua T. Cohen, Ph.D. (Deputy Director), Paige Lin, Ph.D. (Associate Professor and Project Director), Tara Lavelle, Ph.D. (Assistant Professor and Project Director), and their colleagues.
In the second year, the fellow will work directly with the GSK Vaccines Health Outcomes and Epidemiology team in Philadelphia, PA. The team conducts health services research employing methodologies spanning from observational analyses to cost-effectiveness modeling. The fellow will get hands-on experience applying their research expertise in a highly matrixed team environment. The fellow will also gain an understanding of evidence generation strategy and of the US vaccines policy environment.
At GSK, fellows will train under GSK health outcomes scientists whose expertise include health economics, mathematical modeling, psychometrics, field-based health services research, and health policy.
Applicants should have recently completed a PhD or equivalent in health economics, health services research or related research-based discipline, or be planning to complete their degree by the Spring/Summer of 2019. Program requires ability to train first year in Boston, MA and second year in Philadelphia, PA.
Center for the Evaluation of Value and Risk in Health
The Center for the Evaluation of Value and Risk in Health (CEVR) is a member of the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston. The mission of CEVR is to inform the national debate on clinical and public health policy issues and to directly influence the prioritization of healthcare resources both domestically and globally. Researchers at CEVR work on scientific research projects to advance methods development for the field, train the next generation of practitioners and users, and work with policymakers worldwide to develop reasoned policy solutions.
CEVR researchers bring experience in economics and decision analysis to a host of clinical and public health policy issues. The work encompasses formal cost-effectiveness analysis and related techniques, as well as policy research and analysis pertaining to resource allocation. CEVR’s work has enabled it to develop unique databases to help measure and communicate the clinical and economic value of health care strategies.
GlaxoSmithKline (GSK) is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK has 3 global businesses (pharmaceuticals, vaccines and consumer healthcare) that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. GSK aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people. GSK Vaccines has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. We deliver over two million vaccine doses per day to people living in over 160 countries.
To apply for this position, please email a CV and cover letter to Tara Lavelle, Ph.D., or Paige Lin, Ph.D. Please indicate in your cover letter that your application is for the post-doctoral position focused on vaccine research. Applications will be accepted on a rolling basis until the position is filled.